• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
IKE
Click for more information
6.25% 60.0¢

ikeGPS Group Limited

watchlist Created with Sketch. Add to my watchlist

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
IKE
Ann: Notification regarding unquoted securities - IKE 		19/09/24 0 1
19/09/24 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  1 
IKE
Ann: ikeGPS FY19 Performance Update 		25/03/19 0 25
25/03/19 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  25 
IKE
Ann: ikeGPS Q3 FY19 performance update 		25/01/19 0 124
25/01/19 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  124 
IKE
Ann: ikeGPS FY19 Guidance Update 		24/01/19 0 129
24/01/19 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  129 
IKE
Ann: Notification of Issue of Additional Unlisted Options 		14/01/19 0 128
14/01/19 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  128 
IKE
Ann: Notification of Issue of Additional Unlisted Options 		14/01/19 0 127
14/01/19 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  127 
IKE
Ann: Initial disclosure notice - Bill Morrow 		10/01/19 0 127
10/01/19 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  127 
IKE
Ann: ikeGPS appoints Bill Morrow as non - executive director 		20/12/18 0 143
20/12/18 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  143 

See All Discussions arrow Created with Sketch.
(20min delay)
Last
60.0¢ 		Change
-0.040(6.25%) 		Mkt cap ! n/a
Open High Low Value Volume
61.0¢ 61.0¢ 60.0¢ $15.36K 25.57K

Buyers (Bids)

No. Vol. Price($)
0 6 58.0¢
 

Sellers (Offers)

Price($) Vol. No.
62.0¢ 39980 0
Last trade - 11.14am 27/09/2024 (20 minute delay) ?
IKE (NZSX) Chart

Top Stories

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Actinogen Medical is developing a promising oral treatment for Alzheimer's and depression and is accelerating clinical trials with new capital.
5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core Strickland Metals Ltd has found an extensive zone of high-grade gold and base metals mineralisation at its Rogozna project
Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders Estrella has become the first foreign entity to win mining acreage in Timor-Leste under that country's new mining laws enacted in 2021.
Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia Coda Minerals (ASX:COD) CEO, Chris Stevens, joins The Market Online to discuss the company's current rights issue, and how the capital from this raise will be used to further its copper exploration in South Australia. In addition, Chris talks through the journey the company has taken over the last few years since listing until now.
KalGold rolls out detailed aeromagnetic survey across Pinjin project Kalgoorlie Gold Mining Ltd has begun a high-resolution aeromagnetic geophysical survey across the northern parts of the Pinjin project
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.